¼¼°èÀÇ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐÀû ÀÀ¿ë ½ÃÀå
Bovine-Based Collagen for Biomedical Applications
»óǰÄÚµå : 1763119
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐÀû ÀÀ¿ë ½ÃÀåÀº 2030³â±îÁö 15¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 10¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐÀû ÀÀ¿ë ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 6.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ °ñÀÌ½Ä ´ëü¹°Àº CAGR 7.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 5¾ï 2,690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¬°ñ ¼öº¹ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 6,780¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐÀû ÀÀ¿ë ½ÃÀåÀº 2024³â¿¡ 2¾ï 6,780¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 11.3%·Î 2030³â±îÁö 3¾ï 7,630¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.9%¿Í 6.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐÀû ÀÀ¿ë ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼Ò À¯·¡ Äݶó°ÕÀÌ ¹ÙÀÌ¿À¸ÞµðÄà ºÐ¾ß¿¡¼­ Àα⸦ ²ø°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼Ò À¯·¡ Äݶó°ÕÀº »ýü ÀûÇÕ¼º, ´Ù¿ëµµ¼º, »óó Ä¡À¯ ¹× Á¶Á÷ Àç»ýÀ» ÃËÁøÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ »ý¹°ÀÇÇÐ ºÐ¾ß¿¡¼­ Å« Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¼Ò À¯·¡ Äݶó°ÕÀº â»ó ÇǺ¹Àç, °ñÀÌ½ÄÆí, ÁÖ»ç¿ë ÃæÀüÀç µî ´Ù¾çÇÑ ÀÇ·á Á¦Ç°¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÎü Äݶó°Õ°ú ±¸Á¶ÀûÀ¸·Î À¯»çÇϹǷΠÇǺΠº¹¿ø ¹× Àç°Ç ¼ö¼ú¿¡ ÀÌ»óÀûÀ̸ç, ¹Ì¿ë°ú Ä¡·áÀÇ µÎ °¡Áö Ãø¸é ¸ðµÎ¿¡¼­ ÇʼöǰÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸¸¼º »óó Áõ°¡¿Í ÷´Ü »óó °ü¸® Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä´Â ±× äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ ÀÇ·á ºÐ¾ß¿¡¼­ ¼Ò À¯·¡ Äݶó°ÕÀÇ »ç¿ëÀ» ÃËÁøÇϰí Àִ°¡?

¼Ò À¯·¡ Äݶó°ÕÀÇ ÃßÃâ ¹× °¡°ø ±â¼ú Çõ½ÅÀº ƯÈ÷ ¼¶¼¼ÇÑ ¿ëµµ¿¡ ÀûÇÕÇÑ °íµµ·Î Á¤Á¦µÈ ÇüÅÂÀÇ °³¹ß¿¡¼­ ÀÇ·á¿ëÀ¸·ÎÀÇ »ç¿ëÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. µ¿°á °ÇÁ¶ ¹× °¡±³¿Í °°Àº ±â¼úÀº Äݶó°ÕÀÇ ¾ÈÁ¤¼º°ú ¼ö¸íÀ» °³¼±Çϰí Á¶Á÷ °øÇÐ ¹× Àç»ý ÀÇÇп¡¼­ ´õ È¿°úÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ÃÖ±Ù °³¹ß µ¿ÇâÀ¸·Î´Â Äݶó°Õ ½ºÄ³Æúµù°ú ÇÏÀ̵å·Î°ÖÀÌ ÀÖÀ¸¸ç, ¼¼Æ÷ÀÇ ´õ ³ªÀº ÅëÇÕ°ú ¼ºÀå Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á ¼ºÇü¿Ü°ú, ½ÉÇ÷°ü ¼ö¸® ¹× ¹Ì¿ë ¼ºÇüÀÇ °í±Þ Ä¡·áÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

±ÔÁ¦ ±âÁØÀº ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

±ÔÁ¦ ±âÁØÀº ƯÈ÷ ¾ÈÀü ¹× ǰÁú º¸Áõ Ãø¸é¿¡¼­ ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, FDA ¹× EMA¿Í °°Àº ±â°üÀÌ ÀÇ·á¿ë Äݶó°Õ Á¦Ç°¿¡ ´ëÇØ Á¤ÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀº Á¦Á¶¾÷ü°¡ °íǰÁú Ç¥ÁØÀ» ÁؼöÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. ƯÈ÷ µ¿¹° À§»ý ¹× ¾ÈÀü ±ÔÁ¦°¡ ¾ö°ÝÇÑ ±¹°¡·ÎºÎÅÍ ¼Ò Äݶó°ÕÀ» Á¶´ÞÇÏ´Â °ÍÀº ¼ÒÇØ¸é»ó³úÁõ(BSE)°ú °°Àº ¿À¿° À§ÇèÀ» ¹æÁöÇϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ °¨µ¶À» ÅëÇØ Á¦Á¶¾÷ü´Â º¸´Ù ¾ÈÀüÇÑ ÃßÃâ ¹æ¹ý°ú ÷´Ü Á¤Á¦ ±â¼ú¿¡ ÅõÀÚÇÏ°Ô µË´Ï´Ù.

¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹°ÀÇÇÐ ÀÀ¿ë ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼Ò À¯·¡ Äݶó°ÕÀÇ »ý¹° ÀÇÇÐ ÀÀ¿ë ½ÃÀåÀÇ ¼ºÀåÀº ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Äݶó°Õ ±â¹Ý Á¦Ç° °³¹ßÀÇ ¹ßÀü, ¸¸¼º »óó ¹× Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¹°ÁúÀÇ »ýü ÀûÇÕ¼º°ú ¼¼Æ÷ÀÇ ¼ºÀå°ú Ä¡À¯¸¦ ÃËÁøÇÏ´Â È¿°ú´Â Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ Àç»ýÀÇ·á ¹× Á¶Á÷°øÇÐÀÇ Çõ½ÅÀº Äݶó°ÕÀÇ »ç¿ë ¹üÀ§¸¦ È®´ëÇÏ´Â ÇÑÆí, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº Á¦Ç°ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÏ¿© ½ÃÀåÀÇ ½Å·Ú¿Í ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(°ñÀÌ½Ä ´ëü¹°, ¿¬°ñ ¼öº¹, Äݶó°Õ ±â¹Ý ½ºÄ³Æúµå, ÁöÇ÷Á¦, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AIÀÎÅ×±×·¹À̼ÇÁî

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Bovine-Based Collagen for Biomedical Applications Market to Reach US$1.5 Billion by 2030

The global market for Bovine-Based Collagen for Biomedical Applications estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$526.9 Million by the end of the analysis period. Growth in the Cartilage Repair segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$267.8 Million While China is Forecast to Grow at 11.3% CAGR

The Bovine-Based Collagen for Biomedical Applications market in the U.S. is estimated at US$267.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$376.3 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Bovine-Based Collagen for Biomedical Applications Market - Key Trends & Drivers Summarized

Why Is Bovine-Based Collagen Gaining Popularity in Biomedical Applications?

Bovine-based collagen is gaining significant popularity in biomedical applications due to its biocompatibility, versatility, and ability to promote wound healing and tissue regeneration. Collagen derived from bovine sources is widely used in various medical products such as wound dressings, bone grafts, and injectable fillers. Its structural similarity to human collagen makes it ideal for skin repair and reconstructive surgeries, making it a staple in both aesthetic and therapeutic procedures. The increasing prevalence of chronic wounds and the demand for advanced wound care products are further driving its adoption.

What Innovations Are Enhancing the Use of Bovine-Based Collagen in Medicine?

Innovations in the extraction and processing of bovine-based collagen are enhancing its use in medicine, particularly in developing highly purified forms suitable for sensitive applications. Techniques such as lyophilization and cross-linking are being employed to improve collagen stability and longevity, making it more effective in tissue engineering and regenerative medicine. Recent developments include collagen scaffolds and hydrogels that offer better integration and growth support for cells, paving the way for advanced treatments in orthopedics, cardiovascular repair, and cosmetic surgery.

How Are Regulatory Standards Influencing the Bovine-Based Collagen Market?

Regulatory standards play a significant role in influencing the bovine-based collagen market, especially in terms of safety and quality assurance. The strict guidelines set by bodies such as the FDA and EMA for medical-grade collagen products ensure that manufacturers adhere to high-quality standards. The sourcing of bovine collagen, particularly from countries with rigorous animal health and safety regulations, is crucial to prevent contamination risks such as bovine spongiform encephalopathy (BSE). Such regulatory oversight drives manufacturers to invest in safer extraction methods and advanced purification techniques.

What Factors Are Driving the Growth in the Bovine-Based Collagen for Biomedical Applications Market?

The growth in the bovine-based collagen for biomedical applications market is driven by several factors, including the increasing demand for minimally invasive surgeries, advancements in collagen-based product development, and the rising prevalence of chronic wounds and orthopedic disorders. The material’s biocompatibility and effectiveness in promoting cell growth and healing are significant growth drivers. Additionally, innovations in regenerative medicine and tissue engineering are expanding the scope of collagen use, while strict regulatory standards ensure product safety and efficacy, further boosting market confidence and growth.

SCOPE OF STUDY:

The report analyzes the Bovine-Based Collagen for Biomedical Applications market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Bone Graft Substitutes, Cartilage Repair, Collagen Based Scaffolds, Hemostats, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â